FORT WORTH, Texas, May 5, 2020 /PRNewswire/ -- Galderma announces that the U.S. Food and Drug Administration (FDA) has approved Restylane® Kysse for lip augmentation and the correction of upper ...

Launching an aesthetic product during COVID-19 sounds tricky, but Galderma’s looking on the bright side as it rolls out its newly approved Restylane Kysse lip filler. The lip augmentation product got ...

Restylane Eyelight is the first and only product in the U.S. to use NASHA ® Technology to improve the appearance of undereye hollows for up to 18 months 1 DALLAS, June 5, 2023 /PRNewswire/ -- Galderma ...

At ASDS 2025, Galderma unveiled pivotal new data from its range of pioneering Restylane ® hyaluronic acid (HA) injectables, highlighting its versatility in improving the chin profile with Restylane ...

Galderma will present new data on Relfydess (RelabotulinumtoxinA) – the first and only ready-to-use liquid neuromodulator created using PEARL™ Technology, which has now launched in multiple countries ...

Restylane SHAYPE is the firmest hyaluronic acid (HA) injectable available, 1,2* designed for deep injection onto bone 2 and providing a bone-mimicking effect to shape the lower face Powered by new ...

Galderma officially kicked off its latest campaign for Restylane injectables at New York City’s PrideFest on Sunday. Complementing the event's theme of “Unapologetically Us,” Galderma’s “XpresYourself ...

The unsurpassed NASHA technology, which is still used today as the benchmark for fillers, was pioneered by Galderma Galderma, the world's largest independent dermatology company, today marks the 25 th ...

Please provide your email address to receive an email when new articles are posted on . Actress Sharon Stone has partnered with Galderma to launch an international campaign on Restylane products, ...

- Galderma reinforces long-term commitment to meet physician and patient needs in aesthetic and corrective dermatology worldwide Restylane, Perlane and Emervel are manufactured by Galderma and sold by ...

THORNHILL, ON, Jan. 16, 2018 /CNW/ - Building on its legacy over the last 20 years, the Restylane portfolio of safe and natural-looking aesthetic treatments announces the introduction of Restylane ® ...

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it presented new data from its Injectable Aesthetics portfolio and pipeline at the American Society for ...